ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell... ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2162 | -11.75 | 1.84 | 2.03 | 1.43 | 525675 | 1.67436294 | CS |
4 | -0.1262 | -7.21142857143 | 1.75 | 2.205 | 1.43 | 445450 | 1.869812 | CS |
12 | -0.3762 | -18.81 | 2 | 2.265 | 1.43 | 448133 | 1.81996381 | CS |
26 | -1.1062 | -40.5201465201 | 2.73 | 2.747 | 1.43 | 590173 | 2.16302156 | CS |
52 | -0.1962 | -10.7802197802 | 1.82 | 4.44 | 1.18 | 682533 | 2.24140391 | CS |
156 | -7.7762 | -82.7255319149 | 9.4 | 14.19 | 1.12 | 477424 | 3.79559983 | CS |
260 | -7.7762 | -82.7255319149 | 9.4 | 14.19 | 1.12 | 477424 | 3.79559983 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約